Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11284 | 927 | 41.0 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
214 | 20119 | SOMATIC HYPERMUTATION//VDJ RECOMBINATION//CLASS SWITCH RECOMBINATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | B 1 CELLS | Author keyword | 28 | 50% | 4% | 40 |
2 | B1 CELL | Author keyword | 11 | 78% | 1% | 7 |
3 | CD5 B LYMPHOCYTES | Author keyword | 9 | 83% | 1% | 5 |
4 | CD5 | Author keyword | 8 | 15% | 5% | 47 |
5 | B 1A CELLS | Author keyword | 7 | 64% | 1% | 7 |
6 | CD5 B CELLS | Author keyword | 6 | 28% | 2% | 19 |
7 | B 1 CELL | Author keyword | 5 | 40% | 1% | 10 |
8 | B 1B CELL | Author keyword | 5 | 63% | 1% | 5 |
9 | B 2 CELLS | Author keyword | 4 | 67% | 0% | 4 |
10 | LY 1 B CELLS | Author keyword | 4 | 67% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | B 1 CELLS | 28 | 50% | 4% | 40 | Search B+1+CELLS | Search B+1+CELLS |
2 | B1 CELL | 11 | 78% | 1% | 7 | Search B1+CELL | Search B1+CELL |
3 | CD5 B LYMPHOCYTES | 9 | 83% | 1% | 5 | Search CD5+B+LYMPHOCYTES | Search CD5+B+LYMPHOCYTES |
4 | CD5 | 8 | 15% | 5% | 47 | Search CD5 | Search CD5 |
5 | B 1A CELLS | 7 | 64% | 1% | 7 | Search B+1A+CELLS | Search B+1A+CELLS |
6 | CD5 B CELLS | 6 | 28% | 2% | 19 | Search CD5+B+CELLS | Search CD5+B+CELLS |
7 | B 1 CELL | 5 | 40% | 1% | 10 | Search B+1+CELL | Search B+1+CELL |
8 | B 1B CELL | 5 | 63% | 1% | 5 | Search B+1B+CELL | Search B+1B+CELL |
9 | B 2 CELLS | 4 | 67% | 0% | 4 | Search B+2+CELLS | Search B+2+CELLS |
10 | LY 1 B CELLS | 4 | 67% | 0% | 4 | Search LY+1+B+CELLS | Search LY+1+B+CELLS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | B 1 CELLS | 37 | 31% | 11% | 100 |
2 | LY 1 B CELLS | 32 | 52% | 5% | 44 |
3 | REGION GENE EXPRESSION | 24 | 82% | 2% | 14 |
4 | LY 1 B | 22 | 45% | 4% | 36 |
5 | RECOGNIZE PHOSPHATIDYL CHOLINE | 20 | 67% | 2% | 18 |
6 | CD5 | 19 | 27% | 6% | 60 |
7 | PHOSPHATIDYL CHOLINE | 16 | 54% | 2% | 21 |
8 | LY 1 | 10 | 58% | 1% | 11 |
9 | PERITONEAL B CELLS | 8 | 70% | 1% | 7 |
10 | CONVENTIONAL B CELLS | 7 | 53% | 1% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The double life of a B-1 cell: self-reactivity selects for protective effector functions | 2011 | 189 | 142 | 50% |
ORIGIN OF MURINE B-CELL LINEAGES | 1993 | 392 | 125 | 46% |
Natural Antibodies Bridge Innate and Adaptive Immunity | 2015 | 7 | 113 | 23% |
Origins and functions of B-1 cells with notes on the role of CD5 | 2002 | 383 | 275 | 32% |
B-1 B Cell Development in the Fetus and Adult | 2012 | 47 | 82 | 41% |
B-1 cells: the lineage question revisited | 2000 | 160 | 71 | 65% |
CD5 B-CELLS, A FETAL B-CELL LINEAGE | 1994 | 176 | 158 | 52% |
The importance of natural IgM: scavenger, protector and regulator | 2010 | 104 | 100 | 19% |
B-1B cell development | 2006 | 113 | 78 | 47% |
Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential | 2007 | 68 | 90 | 34% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DISCIPLINE IMMUNOL | 3 | 23% | 1.3% | 12 |
2 | EVANS MEM CLIN | 2 | 14% | 1.4% | 13 |
3 | ONCOL CELL BIOL | 2 | 15% | 1.2% | 11 |
4 | BECKMAN B007 | 2 | 43% | 0.3% | 3 |
5 | GENET REPROGRAMMING | 1 | 50% | 0.2% | 2 |
6 | MED HOSP IMMUNOL | 1 | 100% | 0.2% | 2 |
7 | VIRAL PREPARAT | 1 | 29% | 0.4% | 4 |
8 | DISCIPLINA IMUNOL | 1 | 12% | 0.9% | 8 |
9 | CLIN BIOCHEM IMMUNOL CIBICI | 1 | 50% | 0.1% | 1 |
10 | COMPARIT MED | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000213818 | NATURAL IGM ANTIBODIES//STEFAN ANGELOV MICROBIOL//ANTIBODY REPERTOIRES |
2 | 0.0000212298 | RECEPTOR EDITING//SURROGATE LIGHT CHAIN//PRE B CELL RECEPTOR |
3 | 0.0000211482 | ALCAM//CD166//CD6 |
4 | 0.0000189746 | NZB MOUSE//NZB MICE//ERYTHROCYTE BAND 3 |
5 | 0.0000171551 | TL 2 RESPONSE//ADCC REACTION//ANTI IG DEXTRAN |
6 | 0.0000134876 | IG ALLOTYPE//UNITE IMMUNOPHYSIOL MOL//DEXTRAN B512 |
7 | 0.0000134289 | EXPTL IMMUNOL UNIT//BN 52080//GLUCOCORTICOIDS SYNTHETIC |
8 | 0.0000130162 | REGULATORY B CELLS//CD40 ACTIVATED B CELLS//REGULATORY B CELL |
9 | 0.0000111682 | IGA ALPHA 1 ANTITRYPSIN COMPLEX//IGA ALPHA1 ANTITRYPSIN COMPLEX//LOW MOLECULAR WEIGHT IGM |
10 | 0.0000110543 | IGG RHEUMATOID FACTOR//IMMUNOGLOBULIN GENES//CROSS REACTIVE IDIOTYPE |